| Literature DB >> 32717786 |
Anup Sood1, Yunxia Sui1, Elizabeth McDonough1, Alberto Santamaría-Pang1, Yousef Al-Kofahi1, Zhengyu Pang1, Peter B Jahrling2, Jens H Kuhn2, Fiona Ginty1.
Abstract
Over the last 15 years, advances in immunofluorescence-imaging based cycling methods, antibody conjugation methods, and automated image processing have facilitated the development of a high-resolution, multiplexed tissue immunofluorescence (MxIF) method with single cell-level quantitation termed Cell DIVETM. Originally developed for fixed oncology samples, here it was evaluated in highly fixed (up to 30 days), archived monkeypox virus-induced inflammatory skin lesions from a retrospective study in 11 rhesus monkeys to determine whether MxIF was comparable to manual H-scoring of chromogenic stains. Six protein markers related to immune and cellular response (CD68, CD3, Hsp70, Hsp90, ERK1/2, ERK1/2 pT202_pY204) were manually quantified (H-scores) by a pathologist from chromogenic IHC double stains on serial sections and compared to MxIF automated single cell quantification of the same markers that were multiplexed on a single tissue section. Overall, there was directional consistency between the H-score and the MxIF results for all markers except phosphorylated ERK1/2 (ERK1/2 pT202_pY204), which showed a decrease in the lesion compared to the adjacent non-lesioned skin by MxIF vs an increase via H-score. Improvements to automated segmentation using machine learning and adding additional cell markers for cell viability are future options for improvement. This method could be useful in infectious disease research as it conserves tissue, provides marker colocalization data on thousands of cells, allowing further cell level data mining as well as a reduction in user bias.Entities:
Keywords: IHC; MPXV; MxIF; Orthopoxvirus; Poxviridae; immunohistochemistry; monkeypox; monkeypox virus; multiplexed immunofluorescence; poxvirus
Year: 2020 PMID: 32717786 PMCID: PMC7472296 DOI: 10.3390/v12080787
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Orthopoxvirus-associated protein, biomarkers and image segmentation markers used in this study.
|
|
|
|
|
|
|
|
|
| Vaccinia virus | VACV | 8115 | 1 | 2 | MPXV-infected cells | Cytoplasm, membrane | Santa Cruz/sc-58,210 |
| Cluster of differentiation marker 68 | CD68 | KP1 | 5 | 5 | Monocytes/macrophages | Cytoplasm | Thermo Fisher/MS-397-PABX |
| Cluster of differentiation marker 3 | CD3 | F7.2.38 | 6 | 5 | T cells | Membrane | Dako/M7254 |
| Heat shock protein 70 | Hsp70 | EP1007Y | 5 | 5 | Epithelial cells | Cytoplasm and nucleus | Epitomics/1776 |
| Heat shock protein 90 | Hsp90 | C45G5 | 4 | 10 | Epithelial cells | Cytoplasm and nucleus | Cell Signaling/4877 |
| Extracellular signal-regulated kinases 1/2 | ERK1/2 | 137F5 | 4 | 5 | Epithelial cells | Cytoplasm | Cell Signaling/4695 |
| Phosphorylated extracellular signal-regulated kinases 1/2 pT202_pY204 | ERK1/2 pT202_pY204 | 20G11 | 3 | 5 | Epithelial cells | Cytoplasm and nucleus | Cell Signaling/4376 |
|
|
|
|
|
|
|
|
|
| 4′,6′-diamidino-2-phenylindole | DAPI | NA | all | 10,000 | All cells | Nucleus | Thermo Fisher/D3571 |
| Ribosomal protein S6 | RPS6 | 5G10 | 1 | 5 | All cells | Cytoplasm | Cell Signaling/2217 |
| E-cadherin | E-Cad | 24E10 | 2 | 5 | Epithelial membranes | Membrane | Cell Signaling/3195 |
| Pan-cytokeratin (Epithelial marker) | panCK, a cocktail (ratio 1:2) of AE1 and PCK26 | AE1/PCK26 | 2 | 2.5 | Epithelial cells | Cytoplasm | eBioscience/14-9001 & Sigma/C1801 |
| Sodium/potassium ATPase, alpha-1 | Na+/K+-ATPase | EP1845Y | 3 | 5 | Epithelial cells | Membranes | Epitomics/2047 |
All Cell DIVE antibody incubations were conducted at ambient temperature for 1 h. * Santa Cruz Biotechnology, Inc., 10410 Finnell Street, Dallas, TX 75220, USA; Thermo Fisher Scientific, 168 Third Avenue, Waltham, MA 02451, USA; Dako (Agilent) 5301 Stevens Creek Blvd., Santa Clara, CA 95051, USA; Epitomics (Abcam), 1 Kendall Square, Suite B2304, Cambridge, MA 02139, USA; Cell Signaling Technology, 3 Trask Lane, Denvers, MA 01923, USA; eBioscience Inc., 10255 Science Center Drive, San Diego, CA 92121, USA.
Monkeypox virus-positive haired skin sample collection from rhesus monkeys infected at a dose of 5 × 106 PFU.
| Sample No. | Sex | Age at Necropsy | MPXV Isolate | Days Post-inoculation to Necropsy | 10% NBF Fixation Time (d) |
|---|---|---|---|---|---|
| 1 | F | 9 | Zaire 79 | 9 | 29 |
| 2 | F | 10 | Zaire 79 | 8 | 30 |
| 3 | F | 14 | Sierra Leone | 9 | 19 |
| 4 | F | 13 | Zaire 79 | 9 | 29 |
| 5 | M | 4 | Zaire 79 | 8 | 30 |
| 6 | F | 13 | Zaire 79 | 8 | 30 |
| 7 | F | 10 | Sierra Leone | 7 | 21 |
| 8 | M | 9 | Sierra Leone | 8 | 20 |
| 9 | F | 9 | Sierra Leone | 9 | 19 |
| 10 | F | 14 | Sierra Leone | 9 | 19 |
| 11 | F | 5 | Sierra Leone | 8 | 20 |
MPXV—monkeypox; NBF—neutral-buffered formalin.
Figure 1High-level immunohistochemistry (IHC) and multiplex immunofluorescence (MxIF) analysis workflows. Overall, workflows show staining processes and subsequent quantification approaches. (A) Double-stain IHC (one tissue section for each marker of interest and vaccinia virus (VACV)) followed by manual quantification; (B) MxIF workflow involves repeated staining, imaging and signal removal on a single tissue section followed by automated cellular/subcellular segmentation using compartment-specific markers and biomarker quantitation. NHP—nonhuman primate.
Figure 2Examples of virtual hematoxylin and eosin (vH&E) and multiplexed staining by Cell DIVE of VACV, CD3, CD68, ERK1/2, ERK1/2 pT202_pY204, Hsp70 and Hsp90 in archived fixed monkeypox virus-induced skin lesions and in adjacent, nonlesion uninfected skin.
Biomarkers differentially expressed between monkeypox virus-infected and adjacent nonlesion skin regions using IHC and Cell DIVE.
| H-Score | Cell DIVE | |||||||
|---|---|---|---|---|---|---|---|---|
| Adjacent VACV (−) Nonlesion Skin Compared to VACV (+) Lesioned Skin ( | Difference in Mean | Std of Difference | Difference in Mean * | Std of Difference | ||||
| CD68 Dermis | −0.025 | 0.286 | −0.087 | 0.78 | −0.015 | 0.005 | −3.339 | 0.006 |
| CD68 Epithelium | −0.368 | 0.44 | 0.877 | 0.02 | −0.011 | 0.004 | −2.801 | 0.017 |
| CD3 Dermis | 0.17 | 0.509 | 0.334 | 0.292 | −0.015 | 0.006 | −2.416 | 0.034 |
| CD3 Epithelium | −0.53 | 0.838 | −0.632 | 0.062 | 0.005 | 0.003 | 1.6561 | 0.126 |
| Proportion of CD3 cells in the epithelium and stroma | N/A | N/A | N/A | N/A | −0.015 | 0.005 | −2.770 | 0.018 |
| Proportion of CD68 cells in the epithelium and stroma | N/A | N/A | N/A | N/A | −0.0168 | 0.005 | −3.671 | 0.003 |
| Hsp70 epithelium cytoplasm | 0.104 | 0.311 | 0.334 | 0.294 | 0.314 | 0.080 | 3.916 | 0.002 |
| Hsp70 epithelium nucleus | 0.303 | 0.625 | 0.484 | 0.139 | 0.502 | 0.087 | 5.799 | 0.0001 |
| Hsp90 epithelium cytoplasm | −0.106 | 0.21 | −0.505 | 0.169 | 0.109 | 0.106 | 1.030 | 0.325 |
| Hsp90 epithelium nucleus | 0.022 | 0.199 | 0.111 | 0.573 | 0.152 | 0.097 | 1.573 | 0.144 |
| Unphosphorylated ERK1/2 epithelium cytoplasm | 0.295 | 0.324 | 0.910 | 0.013 | 0.377 | 0.071 | 5.284 | 0.0003 |
| Unphosphorylated ERK1/2 epithelium nucleus | 0.133 | 0.347 | 0.383 | 0.234 | 0.395 | 0.080 | 4.913 | 0.0005 |
| Phosphorylated ERK1/2 pT202_pY204 epithelium cytoplasm | 0.01 | 0.219 | 0.046 | 0.833 | 0.482 | 0.120 | 4.036 | 0.002 |
| Phosphorylated ERK1/2 pT202_pY204 epithelium nucleus | −0.189 | 0.17 | 1.11 | 0.004 | 0.604 | 0.112 | 5.379 | 0.0002 |
* The difference in log2 protein expression values with the exception of CD3 and CD68. CD3 and CD68 on Cell DIVE is the difference in proportion of positive cells in the dermis and epidermis. Std: standard deviation.
Figure 3Differential subcellular localization of Hsp70 in adjacent nonlesion vs infected skin regions. In adjacent nonlesion regions, a strong nuclear signal for Hsp70 is observed, whereas in the infected lesion area it is mainly cytoplasmic. For Hsp90, no significant difference in expression was detected in the cytoplasm or nuclei of lesioned skin using IHC or Cell DIVE.
Figure 4Multiplex immunofluorescence, segmentation and quantification. A potential cause of the discrepancy between semiquantitative manual IHC score and automated quantification of pERK1/2 is the inclusion of successfully segmented, but nonviable cells when using Cell DIVE. (A) H&E of monkeypox virus-lesioned skin and adjacent, uninfected skin annotated by a pathologist (top); H&E of the lesion included in the automated quantification (middle); H&E of a single field of view within the lesioned skin (bottom). (B) MPXV-staining in the field of view shown in (A) (top); Automated cellular/subcellular segmentation using compartment and region-specific cell markers (middle, bottom); ERK1/2 pT202_pY204-staining indicated loss of ERK1/2 pT202_pY204 in nonviable cells (bottom).